Target-agnostic discovery of Rett Syndrome therapeutics by coupling computational network analysis and CRISPR-enabled in vivo disease modeling
Preprint
Abstract
Many neurodevelopmental genetic disorders, such as Rett syndrome, are caused by a single gene mutation but trigger changes in expression and regulation of numerous other genes. This severely impair functions of multiple organs and organ systems beyond the central nervous system (CNS), adding to the challenge of developing broadly effective treatments based on a single drug target. This challenge is further complicated by the lack of sufficiently broad and biologically relevant drug screens, and the inherent complexity in identifying clinically relevant targets responsible for diverse phenotypes. Here, we combined human gene regulatory network-based computational drug prediction with in vivo screening in a population-level diversity, CRISPR-edited, Xenopus laevis tadpole model of Rett syndrome to carry out target-agnostic drug discovery, which rapidly led to the identification of the FDA-approved drug vorinostat as a potential repurposing candidate. Vorinostat broadly improved both CNS and non-CNS (e.g., gastrointestinal, respiratory, inflammatory) abnormalities in a pre-clinical mouse model of Rett syndrome. This is the first Rett syndrome treatment to demonstrate pre-clinical efficacy across multiple organ systems when dosed after the onset of symptoms, and network analysis revealed a putative therapeutic mechanism for its cross-organ normalizing effects based on its impact on acetylation metabolism and post-translational modifications of microtubules. Although traditionally considered an inhibitor of histone deacetylases (HDAC), vorinostat unexpectedly restored protein acetylation across both hypo- and hyperacetylated tissues, suggesting non-HDAC-mediated therapeutic mechanisms supported by proteomic analysis.Keywords
This publication has 74 references indexed in Scilit:
- Modeling human neurodevelopmental disorders in theXenopustadpole: from mechanisms to therapeutic targetsDisease Models & Mechanisms, 2013
- Gastrointestinal and Nutritional Problems Occur Frequently Throughout Life in Girls and Women With Rett SyndromeJournal of Pediatric Gastroenterology and Nutrition, 2012
- The role of oxidative stress in Rett syndrome: an overviewAnnals of the New York Academy of Sciences, 2012
- Wild-type microglia arrest pathology in a mouse model of Rett syndromeNature, 2012
- Inferring Regulatory Networks from Expression Data Using Tree-Based MethodsPLOS ONE, 2010
- In vivo imaging of seizure activity in a novel developmental seizure modelExperimental Neurology, 2008
- Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2Proceedings of the National Academy of Sciences, 2007
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006
- Describing the phenotype in Rett syndrome using a population databaseArchives of Disease in Childhood, 2003
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000